CN102666873A - 用于高效率蛋白质表达的分泌蛋白质生物标记物 - Google Patents
用于高效率蛋白质表达的分泌蛋白质生物标记物 Download PDFInfo
- Publication number
- CN102666873A CN102666873A CN2010800503369A CN201080050336A CN102666873A CN 102666873 A CN102666873 A CN 102666873A CN 2010800503369 A CN2010800503369 A CN 2010800503369A CN 201080050336 A CN201080050336 A CN 201080050336A CN 102666873 A CN102666873 A CN 102666873A
- Authority
- CN
- China
- Prior art keywords
- protein
- subunit
- cell
- precursor
- biomarker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25952709P | 2009-11-09 | 2009-11-09 | |
| US61/259527 | 2009-11-09 | ||
| US12/941347 | 2010-11-08 | ||
| US12/941,347 US8524458B2 (en) | 2009-11-09 | 2010-11-08 | Secretory protein biomarkers for high efficiency protein expression |
| PCT/US2010/055953 WO2011057239A2 (en) | 2009-11-09 | 2010-11-09 | Secretory protein biomarkers for high efficiency protein expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102666873A true CN102666873A (zh) | 2012-09-12 |
Family
ID=43431809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010800503369A Pending CN102666873A (zh) | 2009-11-09 | 2010-11-09 | 用于高效率蛋白质表达的分泌蛋白质生物标记物 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8524458B2 (enExample) |
| EP (1) | EP2499254A2 (enExample) |
| JP (1) | JP2013510324A (enExample) |
| KR (1) | KR20120115494A (enExample) |
| CN (1) | CN102666873A (enExample) |
| AU (1) | AU2010314922A1 (enExample) |
| BR (1) | BR112012010976A2 (enExample) |
| CA (1) | CA2778254A1 (enExample) |
| IL (1) | IL219518A0 (enExample) |
| IN (1) | IN2012DN03358A (enExample) |
| MX (1) | MX2012005380A (enExample) |
| RU (1) | RU2012124114A (enExample) |
| WO (1) | WO2011057239A2 (enExample) |
| ZA (1) | ZA201202966B (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108467890A (zh) * | 2018-05-02 | 2018-08-31 | 首都医科大学附属北京天坛医院 | Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品 |
| CN109470756A (zh) * | 2018-10-11 | 2019-03-15 | 昆明理工大学 | 测定14-3-3蛋白与质膜H+-ATPase蛋白互作的电化学方法 |
| JP2019527815A (ja) * | 2016-06-06 | 2019-10-03 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 生体高分子複合体の精製のための方法 |
| CN117099743A (zh) * | 2023-07-11 | 2023-11-24 | 吉林大学 | 一种snx6基因不表达的异种移植供体及制备方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6507542B2 (ja) * | 2014-09-22 | 2019-05-08 | 東洋紡株式会社 | バイオマーカーを用いた組換えタンパク質生産量の予測方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008054514A2 (en) * | 2006-04-21 | 2008-05-08 | Wyeth | Differential expression profiling analysis of cell culture phenotypes and the uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| US5302517A (en) * | 1987-06-16 | 1994-04-12 | The Board Of Regents Of The University Of Nebraska | Method of controlling the expression of a gene in a cell culture, cell culture vector used in the method and method of making the vector |
| EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US20050272055A1 (en) * | 2000-02-01 | 2005-12-08 | Rina Das | Method of treating lethal shock induced by toxic agents and diagnosing exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
| US8242057B2 (en) * | 2006-06-26 | 2012-08-14 | Cleveland Biolabs, Inc. | Methods for identifying modulators of apoptosis |
| JP2011522265A (ja) * | 2008-06-04 | 2011-07-28 | プロテオシス アクチエンゲゼルシャフト | 化学物質の発生毒性及び胚性毒性のinvitro試験のためのタンパク質バイオマーカー |
-
2010
- 2010-11-08 US US12/941,347 patent/US8524458B2/en not_active Expired - Fee Related
- 2010-11-09 BR BR112012010976A patent/BR112012010976A2/pt not_active IP Right Cessation
- 2010-11-09 EP EP10778803A patent/EP2499254A2/en not_active Withdrawn
- 2010-11-09 IN IN3358DEN2012 patent/IN2012DN03358A/en unknown
- 2010-11-09 AU AU2010314922A patent/AU2010314922A1/en not_active Abandoned
- 2010-11-09 WO PCT/US2010/055953 patent/WO2011057239A2/en not_active Ceased
- 2010-11-09 RU RU2012124114/10A patent/RU2012124114A/ru not_active Application Discontinuation
- 2010-11-09 JP JP2012538076A patent/JP2013510324A/ja active Pending
- 2010-11-09 MX MX2012005380A patent/MX2012005380A/es not_active Application Discontinuation
- 2010-11-09 CN CN2010800503369A patent/CN102666873A/zh active Pending
- 2010-11-09 KR KR1020127014730A patent/KR20120115494A/ko not_active Withdrawn
- 2010-11-09 CA CA2778254A patent/CA2778254A1/en not_active Abandoned
-
2012
- 2012-04-23 ZA ZA2012/02966A patent/ZA201202966B/en unknown
- 2012-05-01 IL IL219518A patent/IL219518A0/en unknown
-
2013
- 2013-08-30 US US14/016,035 patent/US20140004531A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008054514A2 (en) * | 2006-04-21 | 2008-05-08 | Wyeth | Differential expression profiling analysis of cell culture phenotypes and the uses thereof |
Non-Patent Citations (1)
| Title |
|---|
| 王巧侠等: "热休克蛋白70和糖调节蛋白94 在人胃癌细胞BGC-823中的表达", 《陕西医学杂志》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019527815A (ja) * | 2016-06-06 | 2019-10-03 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 生体高分子複合体の精製のための方法 |
| US11401301B2 (en) | 2016-06-06 | 2022-08-02 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Method for the purification of biological macromolecular complexes |
| CN108467890A (zh) * | 2018-05-02 | 2018-08-31 | 首都医科大学附属北京天坛医院 | Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品 |
| CN109470756A (zh) * | 2018-10-11 | 2019-03-15 | 昆明理工大学 | 测定14-3-3蛋白与质膜H+-ATPase蛋白互作的电化学方法 |
| CN109470756B (zh) * | 2018-10-11 | 2020-08-25 | 昆明理工大学 | 测定14-3-3蛋白与质膜H+-ATPase蛋白互作的电化学方法 |
| CN117099743A (zh) * | 2023-07-11 | 2023-11-24 | 吉林大学 | 一种snx6基因不表达的异种移植供体及制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| US8524458B2 (en) | 2013-09-03 |
| MX2012005380A (es) | 2012-05-29 |
| AU2010314922A1 (en) | 2012-05-31 |
| WO2011057239A3 (en) | 2011-06-30 |
| JP2013510324A (ja) | 2013-03-21 |
| KR20120115494A (ko) | 2012-10-18 |
| BR112012010976A2 (pt) | 2016-08-16 |
| WO2011057239A2 (en) | 2011-05-12 |
| US20140004531A1 (en) | 2014-01-02 |
| RU2012124114A (ru) | 2013-12-20 |
| IN2012DN03358A (enExample) | 2015-10-23 |
| EP2499254A2 (en) | 2012-09-19 |
| IL219518A0 (en) | 2012-06-28 |
| CA2778254A1 (en) | 2011-05-12 |
| US20110236906A1 (en) | 2011-09-29 |
| ZA201202966B (en) | 2012-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Budnik et al. | SCoPE-MS: mass spectrometry of single mammalian cells quantifies proteome heterogeneity during cell differentiation | |
| Evers et al. | Deciphering metabolic heterogeneity by single-cell analysis | |
| Boersema et al. | Proteomics beyond large-scale protein expression analysis | |
| Webb et al. | Modified MuDPIT separation identified 4488 proteins in a system-wide analysis of quiescence in yeast | |
| Baharvand et al. | Concise review: trends in stem cell proteomics | |
| JP5682986B2 (ja) | 質量分析における安定同位体標識標的ペプチド断片の作製方法 | |
| US11719703B2 (en) | Mass spectrometry technique for single cell proteomics | |
| Huang et al. | SNaPP: simplified nanoproteomics platform for reproducible global proteomic analysis of nanogram protein quantities | |
| Liu et al. | Deep profiling of microgram-scale proteome by tandem mass tag mass spectrometry | |
| Dong et al. | A “tagless” strategy for identification of stable protein complexes genome-wide by multidimensional orthogonal chromatographic separation and iTRAQ reagent tracking | |
| Zhu et al. | Capillary isoelectric focusing-tandem mass spectrometry and reversed-phase liquid chromatography-tandem mass spectrometry for quantitative proteomic analysis of differentiating PC12 cells by eight-plex isobaric tags for relative and absolute quantification | |
| US20140004531A1 (en) | Secretory Protein Biomarkers For High Efficiency Protein Expression | |
| Franciosa et al. | Proteomics to study cancer immunity and improve treatment | |
| Muschong et al. | Improvement of Workflows and Assay Reproducibility by The Introduction of “Assay-Ready” Culturing of MDCK Cells for Transport Studies | |
| Brenes et al. | Proteomic and functional comparison between human induced and embryonic stem cells | |
| Dörrbaum et al. | Dynamic SILAC to determine protein turnover in neurons and glia | |
| Yan et al. | Ribosomal proteomics: Strategies, approaches, and perspectives | |
| Wang et al. | Proteomic studies of stem cells | |
| Schmidt et al. | Quantitative peptide and protein profiling by mass spectrometry | |
| Bortecen | Analyzing the individual contributions of translation initiation factors to shaping the proteome of cancer cells | |
| TW201140050A (en) | Secretory protein biomarkers for high efficiency protein expression | |
| Feola et al. | PeptiCHIP: a novel microfluidic-based chip platform for tumour antigen landscape identification | |
| Goeminne | Statistical methods for differential proteomics at peptide and protein level | |
| Baker et al. | Single-Cell Protein Assays in Context: From 2D to 3D and In Situ Analysis | |
| Florczak | Quantitative Analysis of Proteome Dynamics in Chinese Hamster Ovary Cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ABBVIE COMPANY Free format text: FORMER OWNER: ABBOTT GMBH. + CO. KG Effective date: 20130619 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20130619 Address after: Illinois State Applicant after: ABBVIE company Address before: Illinois State Applicant before: Abbott GmbH. & Co. Kg |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120912 |